FDA insists that oestrogen products for menopause carry a warning.
Gottlieb
Scott
S
D004338:Drug Combinations; D004348:Drug Labeling; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D010353:Patient Education as Topic; D011372:Progestins / Q000009:adverse effects*; D012307:Risk Factors; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D004967:Estrogens; D011372:Progestins